Hong JH

No ORCID on file · 5 papers in corpus
other 2020
Cancer research and treatment ·doi:10.4143/crt.2019.292

PURPOSE: The purpose of this study was to evaluate clinical characteristics and treatment pattern of ovarian clear cell carcinoma (OCCC) in Korea and the role of adjuvant chemotherapy in early stage. MATERIALS AND METHODS: Medical records …

2014
JSLS : Journal of the Society of Laparoendoscopic Surgeons ·doi:10.4293/jsls.2014.00335

Background and objectivesStudies of patients with benign pathologic lesions who underwent laparoscopic radical nephroureterectomy (RNU) with preoperative suspicion of upper urinary tract urothelial carcinoma are lacking. The aim of this ret…

2013
Obstetrics & gynecology science ·doi:10.5468/ogs.2013.56.2.126

Multicystic benign mesothelioma (MBM) of the peritoneum is a very rare condition. Since the first description of MBM in 1979, approximately 100 cases have been reported. This is a case report of MBM of the pelvic peritoneum presenting as ac…

article 2007
Journal of clinical laboratory analysis ·doi:10.1002/jcla.20168

As the best-known tumor marker for ovarian carcinoma, CA 125 has also been commonly used to monitor patients with common benign gynecologic diseases such as endometriosis and leiomyoma. Both of these benign tumors are known to be at risk of…

2000
The Biochemical journal ·doi:10.1042/bj3500131

Inflammatory cytokines such as tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) synergistically activate expression of the RANTES (regulated upon activation, normal T-cell expressed and secreted) gene, which plays a…